Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Bullboard Posts
Post by Youhillmanon May 12, 2020 8:54am
142 Views
Post# 31015795

May’s Corporate Presentation

May’s Corporate Presentation

Is finally on CRDL's website, nothing appears new In the update.

Presentation references 'Launch the CBD in the CDN Market' and 'Agreement in place with Shoppers', the same wording as March & April's presentation which seems to indicate little forward progress given its 2 months ago the Shoppers deal was announced. I would have expected something more substantial at this point. 

It's also interesting to note, CRDL still isn't listed as one of the Brands Shoppers is carrying, which again is strange given t2 months have passed.

Perhaps the inventory is being directed to COVID-19 patients given the patent CRDL filed last week, which would be a big positive for CRDL.

Something doesn't seem right, so I look forward to hearing CRDL's earnings update next week

https://www.cardiolrx.com/wp-content/uploads/2020/05/Cardiol-Therapeutics-Presentation-May-2020.pdf

Bullboard Posts